Mount Sinai appoints director of gastrointestinal oncology program
Click Here to Manage Email Alerts
Deirdre J. Cohen, MD, MS, has been appointed director of the gastrointestinal oncology program at Mount Sinai Health System.
Cohen also will lead the cancer clinical trials office at The Tisch Cancer Institute at Mount Sinai, and she will serve as associate professor of medicine at Icahn School of Medicine at Mount Sinai.
Cohen — known for her expertise in pancreatic cancer and other GI malignancies — has served as principal investigator on several trials of novel therapeutic approaches.
“We are very proud that Dr. Cohen has decided to join us to help lead our efforts in gastrointestinal cancers,” Ramon Parsons, MD, PhD, director of The Tisch Cancer Institute at Mount Sinai, chair of oncological sciences and Ward-Coleman professor in cancer research at Icahn School of Medicine, said in a press release. “We are excited to welcome her to also further develop our already robust clinical trial office.”
Cohen spent 13 years on the faculty in the division of medical oncology at New York University. She also served as medical director for Perlmutter Cancer Center’s clinical trials office, as well as acting director of GI medical oncology at NYU.
“Dr. Cohen’s arrival is an exciting step forward for coordinating a multidisciplinary approach for gastrointestinal cancer that builds on a strong foundation already here,” William K. Oh, MD, chief of hematology and medical oncology and deputy director of The Tisch Cancer Institute at Mount Sinai, said in the release. “We are driven to continue to develop more effective therapies in trials for a constellation of cancers that take so many lives every year.”
Click Here to Manage Email Alerts